Reports and Surveys | August 20, 2020

Q2 Update to the 2020 Investment Outlook: A Shot in the Arm

Just what the doctor ordered in the midst of a pandemic: a massive fiscal dose in one arm followed by a record-breaking monetary injection in the other. While this was more substantial in the U.S. than in many other countries, the level of global policy commitments was much greater than what occurred after the Global Financial Crisis (GFC) and were applied with a needed urgency. The path forward from here for investors, however, is in many ways similar to the virus itself — every day we learn a little bit more, but there still isn’t clarity regarding where to plant our next step as we trek towards the hoped-for COVID-free future.

Segal Marco Advisors’ Q2 Update to the 2020 Investment Outlook  helps you put recent market developments in perspective. Learn more about our global macroeconomic views and near-term performance expectations for specific asset classes.

Over the next 12 to 18 months, we expect*:

  • U.S. small cap and developed non-U.S. equity to perform below our long-term assumptions
  • Emerging market equity to deliver returns that are in line with our long-term assumption
  • Returns for U.S. core fixed income that are below our long-term assumptions
  • Returns for non-U.S. core bonds will be challenged
  • A difficult environment for most investments in timber, real estate, commodities and private equity

*The views represented for each of the asset classes are relative to our 10-year capital market assumptions.

Want All the Details?

Q2 Update to the 2020 Investment Outlook Get the Report

Questions about our Q2 update?

Get in touch. See how we can help.

Contact Us

See more insights

Senior Couple With Nordic Walking Poles Hiking In Snow Covered Winter Nature

Ontario’s Consultation on a New Funding Regime for MEPPs

Ontario’s Ministry of Finance proposes regulations for implementing a permanent target benefit framework for Multi-Employer Pension Plans (MEPPs).
Businessman Standing At Window In Conference Room

"2023: The Year of the Rabbit” Investment Outlook

As tough as 2022 was for financial assets, it has set up a very positive starting point for 2023. Get our insights in our latest Investment Outlook.
Male Pharmacist Assisting A Customer At The Prescription Counter

Ontario Drug Benefit Program Changes Biologics Coverage

Learn more about Ontario’s new policy on the use of biosimilars and see how this change might affect your plan.

Don't miss out. Join 16,000 others who already get the latest insights from Segal.